Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiology | 3 | 2021 | 530 | 1.060 |
Why?
|
| Exercise Test | 2 | 2016 | 312 | 0.880 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2020 | 167 | 0.650 |
Why?
|
| Crowdsourcing | 1 | 2018 | 21 | 0.650 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2019 | 163 | 0.610 |
Why?
|
| Acute Coronary Syndrome | 1 | 2020 | 259 | 0.600 |
Why?
|
| Fellowships and Scholarships | 1 | 2021 | 390 | 0.590 |
Why?
|
| Aortic Diseases | 1 | 2019 | 206 | 0.560 |
Why?
|
| Fibrinolytic Agents | 1 | 2019 | 324 | 0.560 |
Why?
|
| Ventricular Dysfunction | 1 | 2015 | 33 | 0.510 |
Why?
|
| Education, Medical, Graduate | 1 | 2021 | 671 | 0.510 |
Why?
|
| Consensus | 1 | 2018 | 978 | 0.490 |
Why?
|
| Periodicals as Topic | 1 | 2018 | 338 | 0.480 |
Why?
|
| Aorta, Thoracic | 1 | 2019 | 546 | 0.470 |
Why?
|
| Fontan Procedure | 1 | 2016 | 155 | 0.470 |
Why?
|
| Heart Septal Defects | 3 | 2018 | 51 | 0.470 |
Why?
|
| Coronary Angiography | 2 | 2016 | 598 | 0.460 |
Why?
|
| Down Syndrome | 1 | 2016 | 226 | 0.450 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2016 | 218 | 0.450 |
Why?
|
| Thrombosis | 1 | 2019 | 781 | 0.420 |
Why?
|
| Tachycardia, Ventricular | 1 | 2015 | 239 | 0.420 |
Why?
|
| Arterial Pressure | 1 | 2012 | 107 | 0.420 |
Why?
|
| Myocardial Ischemia | 1 | 2016 | 435 | 0.410 |
Why?
|
| Pediatrics | 1 | 2021 | 1141 | 0.400 |
Why?
|
| Chest Pain | 1 | 2012 | 155 | 0.400 |
Why?
|
| Hypertension, Pulmonary | 2 | 2016 | 462 | 0.400 |
Why?
|
| Heart Defects, Congenital | 5 | 2020 | 1697 | 0.380 |
Why?
|
| Heart Ventricles | 1 | 2016 | 846 | 0.380 |
Why?
|
| Electrocardiography | 1 | 2016 | 1145 | 0.360 |
Why?
|
| Echocardiography | 4 | 2020 | 1182 | 0.340 |
Why?
|
| Pulmonary Artery | 1 | 2012 | 499 | 0.330 |
Why?
|
| Heart Diseases | 1 | 2012 | 732 | 0.270 |
Why?
|
| Child | 12 | 2021 | 29154 | 0.270 |
Why?
|
| Heart-Assist Devices | 1 | 2015 | 1171 | 0.260 |
Why?
|
| LIM Domain Proteins | 2 | 2014 | 104 | 0.230 |
Why?
|
| Heart Murmurs | 1 | 2021 | 14 | 0.200 |
Why?
|
| Job Application | 1 | 2021 | 19 | 0.190 |
Why?
|
| Heart Failure | 1 | 2015 | 2516 | 0.190 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2021 | 92 | 0.190 |
Why?
|
| Brain Infarction | 1 | 2020 | 31 | 0.180 |
Why?
|
| DiGeorge Syndrome | 1 | 2020 | 77 | 0.180 |
Why?
|
| Myxoma | 1 | 2020 | 63 | 0.180 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2021 | 137 | 0.180 |
Why?
|
| Physical Examination | 1 | 2021 | 299 | 0.180 |
Why?
|
| Education, Distance | 1 | 2020 | 93 | 0.170 |
Why?
|
| Hospitals, Pediatric | 2 | 2016 | 773 | 0.170 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2018 | 1237 | 0.170 |
Why?
|
| Career Choice | 1 | 2021 | 232 | 0.170 |
Why?
|
| Tetralogy of Fallot | 1 | 2020 | 149 | 0.170 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 196 | 0.160 |
Why?
|
| Heart Neoplasms | 1 | 2020 | 214 | 0.160 |
Why?
|
| Infant | 5 | 2020 | 13310 | 0.150 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2018 | 133 | 0.150 |
Why?
|
| Learning | 1 | 2020 | 403 | 0.150 |
Why?
|
| Computed Tomography Angiography | 1 | 2019 | 234 | 0.150 |
Why?
|
| Humans | 21 | 2021 | 261506 | 0.140 |
Why?
|
| Thrombolytic Therapy | 1 | 2019 | 257 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2014 | 1439 | 0.140 |
Why?
|
| Aorta | 1 | 2020 | 692 | 0.140 |
Why?
|
| Aortic Valve | 1 | 2020 | 581 | 0.140 |
Why?
|
| Clinical Competence | 2 | 2020 | 1270 | 0.130 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 500 | 0.130 |
Why?
|
| Vascular Resistance | 1 | 2016 | 200 | 0.130 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 219 | 0.120 |
Why?
|
| Muscle, Striated | 1 | 2014 | 14 | 0.120 |
Why?
|
| Enalapril | 1 | 2014 | 20 | 0.120 |
Why?
|
| Captopril | 1 | 2014 | 34 | 0.120 |
Why?
|
| Seizures | 1 | 2020 | 989 | 0.120 |
Why?
|
| Male | 9 | 2020 | 123000 | 0.120 |
Why?
|
| Risk Factors | 4 | 2018 | 17523 | 0.120 |
Why?
|
| Infant, Newborn | 4 | 2021 | 8223 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2021 | 806 | 0.120 |
Why?
|
| Internship and Residency | 2 | 2021 | 1375 | 0.110 |
Why?
|
| Diagnosis, Differential | 2 | 2020 | 4744 | 0.110 |
Why?
|
| Muscle Proteins | 2 | 2014 | 549 | 0.110 |
Why?
|
| Airway Obstruction | 1 | 2016 | 261 | 0.110 |
Why?
|
| Retrospective Studies | 7 | 2020 | 37905 | 0.110 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2012 | 36 | 0.110 |
Why?
|
| Myocarditis | 1 | 2015 | 190 | 0.110 |
Why?
|
| ROC Curve | 1 | 2016 | 1183 | 0.110 |
Why?
|
| Angina Pectoris | 1 | 2012 | 80 | 0.110 |
Why?
|
| Vasoconstriction | 1 | 2012 | 104 | 0.110 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2012 | 44 | 0.110 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2014 | 257 | 0.100 |
Why?
|
| Heart Conduction System | 1 | 2012 | 165 | 0.100 |
Why?
|
| Adolescent | 4 | 2018 | 31252 | 0.100 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2015 | 473 | 0.100 |
Why?
|
| Proportional Hazards Models | 2 | 2018 | 4988 | 0.100 |
Why?
|
| Graft Rejection | 1 | 2015 | 834 | 0.090 |
Why?
|
| Female | 10 | 2020 | 141928 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 610 | 0.080 |
Why?
|
| Pacemaker, Artificial | 1 | 2011 | 213 | 0.080 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 5687 | 0.080 |
Why?
|
| Kidney Diseases | 1 | 2014 | 691 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2012 | 554 | 0.080 |
Why?
|
| Heart Transplantation | 1 | 2015 | 908 | 0.080 |
Why?
|
| Myocytes, Cardiac | 1 | 2012 | 764 | 0.070 |
Why?
|
| Coronary Vessels | 1 | 2011 | 665 | 0.070 |
Why?
|
| Brain | 1 | 2020 | 4113 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 2012 | 899 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2014 | 1664 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 6207 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2020 | 7702 | 0.070 |
Why?
|
| Texas | 1 | 2016 | 6311 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 14889 | 0.060 |
Why?
|
| Palliative Care | 1 | 2016 | 2037 | 0.060 |
Why?
|
| Postoperative Complications | 2 | 2018 | 5542 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 4892 | 0.060 |
Why?
|
| Age Factors | 1 | 2012 | 5377 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 3343 | 0.050 |
Why?
|
| Survival Rate | 1 | 2016 | 12221 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 3552 | 0.050 |
Why?
|
| Intracranial Embolism | 1 | 2020 | 39 | 0.050 |
Why?
|
| Medical Staff, Hospital | 1 | 2020 | 118 | 0.050 |
Why?
|
| Facial Paralysis | 1 | 2020 | 60 | 0.050 |
Why?
|
| Gastrostomy | 1 | 2020 | 180 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2018 | 32848 | 0.040 |
Why?
|
| Tracheostomy | 1 | 2020 | 243 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2018 | 6869 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2014 | 11965 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2018 | 422 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2020 | 898 | 0.030 |
Why?
|
| Cell Line | 2 | 2014 | 5114 | 0.030 |
Why?
|
| Health Personnel | 1 | 2020 | 625 | 0.030 |
Why?
|
| Curriculum | 1 | 2020 | 860 | 0.030 |
Why?
|
| Prognosis | 1 | 2012 | 21713 | 0.030 |
Why?
|
| Ankyrin Repeat | 1 | 2014 | 15 | 0.030 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2014 | 17 | 0.030 |
Why?
|
| Time Factors | 2 | 2018 | 12926 | 0.030 |
Why?
|
| Actinin | 1 | 2014 | 21 | 0.030 |
Why?
|
| Reoperation | 1 | 2018 | 1382 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2014 | 77 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2020 | 1863 | 0.030 |
Why?
|
| Young Adult | 1 | 2012 | 21445 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2014 | 367 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2014 | 234 | 0.030 |
Why?
|
| Cytochalasin D | 1 | 2012 | 19 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2018 | 1274 | 0.030 |
Why?
|
| Connectin | 1 | 2012 | 30 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2018 | 16273 | 0.030 |
Why?
|
| Naphthalenes | 1 | 2012 | 83 | 0.030 |
Why?
|
| Creatinine | 1 | 2014 | 531 | 0.030 |
Why?
|
| Azepines | 1 | 2012 | 124 | 0.030 |
Why?
|
| Protein Transport | 1 | 2014 | 734 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2014 | 842 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2012 | 388 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 2218 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 4298 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 507 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 1070 | 0.020 |
Why?
|
| Binding Sites | 1 | 2014 | 2171 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2014 | 787 | 0.020 |
Why?
|
| Protein Binding | 1 | 2014 | 3438 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2012 | 1529 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 3101 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 3536 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2020 | 12873 | 0.020 |
Why?
|
| Rats | 1 | 2012 | 6086 | 0.010 |
Why?
|
| Kidney | 1 | 2012 | 2146 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 7548 | 0.010 |
Why?
|
| Animals | 2 | 2014 | 59536 | 0.010 |
Why?
|
| Mutation | 1 | 2014 | 15179 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 34495 | 0.010 |
Why?
|